Pharmacogenomics of Alcohol and Drugs of Abuse

Front Cover
Amitava Dasgupta, Loralie J. Langman
CRC Press, Apr 23, 2012 - Medical - 252 pages

Pharmacogenomics is the basis of personalized medicine, which is said to be the medicine of the future. Understanding genetic variation in drug and alcohol response is vital for professionals working in rehabilitation programs. The same principles that are applicable for therapeutic drugs are also applicable for drugs of abuse. Pharmacogenomics can supplement traditional therapeutic drug monitoring, potentially predicting correct dosage before initiation of the drug therapy.

Applying these principles to testing and treatment, Pharmacogenomics of Alcohol and Drugs of Abuse discusses the role of the clinical laboratory in the practice of personalized medicine. With contributions from a range of experts, the book presents the genetic aspects of alcohol metabolism and other drugs including marijuana, cocaine, and amphetamines. In addition to basic pharmacogenomic aspects, the book addresses slate and trait markers of drugs of abuse so readers can consider setting appropriate biomarker tests in their clinical laboratory.


What people are saying - Write a review

We haven't found any reviews in the usual places.


Pharmacogenomics Principles of Alcohol and DOA
Alcohol Use and Abuse
Slate and Trait Markers of Alcohol Abuse
Introduction to Drugs of Abuse
Pharmacogenomics of Amphetamine and Related Drugs
Pharmacogenomics of Cocaine
Genetic Aspect of Marijuana Metabolism and Abuse
Genetic Aspect of Opiate Metabolism and Addiction
Pharmacogenomics Aspects of Addiction Treatment
Methodologies in Pharmacogenetics Testing
Back Cover

Other editions - View all

Common terms and phrases

About the author (2012)

Amitava Dasgupta is a Professor of Pathology and Laboratory Medicine at the University of Texas-Houston Medical School. Loralie Langman is an Associate Professor of Laboratory Medicine at the Mayo Clinic, Rochester, Minnesota.

Bibliographic information